Biotech MGI and HKBU Collaborate on Advanced Sequencing Technology to Combat Doping in Sports July 26, 2024
Biotech Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis July 26, 2024
Biotech AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis July 26, 2024
Biotech Innovent and WeComput Announce Strategic Partnership to Advance AI-Driven Drug Discovery and Development July 26, 2024
Biotech IASO Bio Announces NMPA Approval of IND Application for IASO-782 for Treatment of New Indication — Systemic Lupus Erythematosus (SLE) July 25, 2024
Biotech Ariceum Therapeutics Commences Phase 1 Clinical Trial in Patients with Recurrent Glioblastoma July 25, 2024
Biotech Merdury signs MOU with Health2Sync to conduct trial of Merdury’s StackDose technology intended for usage in GLP-1 (semaglutide) medication July 25, 2024
Biotech A Novel Way to Reduce Alzheimer’s Amyloid Plaque Burden, Phase 2 Clinical Trial Results of T3D-959 to be Presented by T3D Therapeutics at AAIC July 24, 2024
Biotech Aragen Life Sciences Ltd. receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery and Development Services July 24, 2024
Biotech Nasal Polyposis Treatment Market to Reach US$ 6.8 Bn by 2034, Fueled by Rising Demand for Non-invasive Options: Transparency Market Research, Inc. July 23, 2024